TRAF4/6 Is Needed for CD44 Cleavage and Migration via RAC1 Activation

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• The hyaluronan receptor CD44 plays a role in cancer progression.
• CD44 intracellular domain translocation to the nucleus influences gene transcription.
• Proteolytic cleavage of CD44 releases its intracellular domain.

Purpose of the Study:

• To investigate the role of transforming growth factor-beta (TGFβ) in CD44 cleavage.
• To identify the ubiquitin ligases involved in TGFβ-mediated CD44 cleavage.
• To elucidate the mechanism by which CD44 signaling promotes tumor cell migration.

Main Methods:

• Utilized A549 lung cancer cells and other cell lines.
• Employed TGFβ stimulation to study CD44 cleavage.
• Investigated the involvement of tumor necrosis factor receptor-associated factors (TRAF4/6) and RAC1.
• Used siRNA-mediated knockdown and constitutively active RAC1 mutants.

Main Results:

• TGFβ promotes CD44 cleavage in a TRAF4/6-dependent manner.
• Stem-like A549 cells show increased TRAF4-dependent CD44 variant expression, cleavage, and hyaluronan synthesis.
• TRAF4 activates the small GTPase RAC1, which mediates CD44-dependent cell migration.
• Inhibition of TRAF4 reduces cell migration, which can be rescued by active RAC1.

Conclusions:

• TRAF4/6 mediates the pro-tumorigenic effects of CD44.
• The TRAF4/6-RAC1 signaling axis is crucial for CD44-driven lung cancer cell migration.
• Targeting CD44 signaling via TRAF4/6 and RAC1 may offer therapeutic strategies for cancer treatment.